Prohibits cost-sharing on certain health insurance, Oregon Educators Benefit Board and Public Employees' Benefit Board coverage of cervical cancer screenings and follow-up examinations.
Summary
SB 1527 requires health insurers in Oregon that cover cervical cancer screening to provide that coverage without deductibles, coinsurance, copayments, or other out-of-pocket costs when the screening is medically necessary. The bill also extends the same no-cost-sharing requirement to medically necessary follow-up examinations after an abnormal screening result, including diagnostic testing such as colposcopy, biopsy, additional cytology, and human papillomavirus testing. The bill defines cervical cancer screening and follow-up examination for purposes of the new coverage mandate and specifies that the screening mandate does not apply to services primarily used to treat diagnosed cervical cancer.
The bill also amends the statutes governing the Public Employees’ Benefit Board and the Oregon Educators Benefit Board to require those public employee health plans to comply with the new cervical cancer screening and follow-up coverage rule. It further updates the Insurance Code definition section used for health benefit plan regulation so the new mandate is incorporated into the broader framework for group and individual health plans. The coverage requirement applies to policies or certificates issued, renewed, or extended on or after the effective date, and the public-employee plan amendments apply to plans issued, renewed, extended, or in effect for periods beginning on or after that date.
The overall sentiment around the bill appears strongly supportive and noncontroversial. It passed the Senate committee 5-0, the Senate floor 29-0, the House committee 8-0, and the House floor 51-0, indicating unanimous support at every recorded stage. The bill’s caption and structure suggest it is framed as a preventive care and access measure rather than a broader insurance overhaul.
There is little evidence of substantive opposition in the available record, and no committee transcript excerpts were provided showing debate. The main policy issue implicit in the bill is the cost shift to carriers and public benefit plans from eliminating patient cost-sharing for these services, but no recorded votes or discussion indicate that this was a point of contention. Any practical concerns would likely center on insurance premium impacts, administrative implementation, and how broadly “medically necessary” follow-up testing is interpreted, but those concerns are not reflected in the voting history provided.
Impact
SB 1527 adds a new insurance-code requirement prohibiting cost-sharing for medically necessary cervical cancer screenings and related follow-up examinations in group and individual health benefit plans. It also makes conforming changes to the statutes governing PEBB and OEBB so those public employee plans must cover the same services without member cost-sharing. The bill therefore expands mandated preventive coverage and affects insurers, public employee benefit administrators, and enrollees in state-regulated health plans.
Sentiment
The bill received unanimous support in both chambers and in committee, with no recorded dissenting votes. That voting pattern indicates broad bipartisan agreement and a generally favorable sentiment toward expanding access to cervical cancer screening and follow-up care without out-of-pocket costs.
Contention
No major contention is evident in the available record. The likely policy tradeoff is that insurers and public benefit plans must absorb the cost of eliminating deductibles, copays, and coinsurance for these services, but the bill’s unanimous votes suggest that any cost or implementation concerns did not generate visible opposition. The only potentially debatable issues are the scope of covered follow-up testing and how the medical-necessity standard is applied.